Montelukast does not inhibit the late phase reaction in Parthenium dermatitis.
作者信息
Chembolli Lakshmi, Srinivas C R
出版信息
Indian J Dermatol. 2009;54(1):94. doi: 10.4103/0019-5154.49006.
Abstract
摘要
相似文献
1
Montelukast does not inhibit the late phase reaction in Parthenium dermatitis.
Indian J Dermatol. 2009;54(1):94. doi: 10.4103/0019-5154.49006.
2
Parthenium dermatitis.
Dermatitis. 2007 Dec;18(4):183-90. doi: 10.2310/6620.2007.06003.
3
Parthenium dermatitis.
Photochem Photobiol Sci. 2013 Jan;12(1):85-94. doi: 10.1039/c2pp25186h.
4
Dermatitis Severity Score to Assess Clinical Severity of Disease.
Indian J Dermatol. 2017 Jan-Feb;62(1):85-87. doi: 10.4103/0019-5154.198037.
5
Seasonal Variation in Contact Hypersensitivity to Parthenium in Patients of Parthenium Dermatitis.
Indian J Dermatol. 2016 Jan-Feb;61(1):53-6. doi: 10.4103/0019-5154.174026.
6
Parthenium dermatitis: is parthenolide an effective choice for patch testing?
Contact Dermatitis. 2014 Jun;70(6):340-3. doi: 10.1111/cod.12194. Epub 2014 Mar 11.
7
Type I hypersensitivity to Parthenium hysterophorus in patients with parthenium dermatitis.
Indian J Dermatol Venereol Leprol. 2007 Mar-Apr;73(2):103-5. doi: 10.4103/0378-6323.31895.
8
Parthenium dermatitis in India: past, present and future.
Indian J Dermatol Venereol Leprol. 2012 Sep-Oct;78(5):560-8. doi: 10.4103/0378-6323.100522.
9
Evolution of clinical pattern of parthenium dermatitis: a study of 74 cases.
Contact Dermatitis. 2005 Aug;53(2):84-8. doi: 10.1111/j.0105-1873.2005.00652.x.
10
Immunogenetics of cytokine genes in parthenium dermatitis: a review.
Eur Ann Allergy Clin Immunol. 2018 Mar;50(2):59-65. doi: 10.23822/EurAnnACI.1764-1489.40. Epub 2017 Nov 27.
引用本文的文献
1
Parthenium the terminator: An update.
Indian Dermatol Online J. 2012 May;3(2):89-100. doi: 10.4103/2229-5178.96698.
本文引用的文献
1
Type I hypersensitivity to Parthenium hysterophorus in patients with parthenium dermatitis.
Indian J Dermatol Venereol Leprol. 2007 Mar-Apr;73(2):103-5. doi: 10.4103/0378-6323.31895.
2
Leukotriene inhibitors in the treatment of allergy and asthma.
Am Fam Physician. 2007 Jan 1;75(1):65-70.
3
Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine.
Indian J Dermatol Venereol Leprol. 2006 Jul-Aug;72(4):312-4. doi: 10.4103/0378-6323.26735.
4
Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
Acta Dermatovenerol Alp Pannonica Adriat. 2005 Sep;14(3):115-9.
5
Leukotriene receptor antagonists are ineffective for severe atopic dermatitis.
J Am Acad Dermatol. 2004 Mar;50(3):485-6. doi: 10.1016/s0190-9622(03)00758-8.
6
Treatment of asthma with drugs modifying the leukotriene pathway.
N Engl J Med. 1999 Jan 21;340(3):197-206. doi: 10.1056/NEJM199901213400306.
7
Successful treatment of chronic urticaria with leukotriene antagonists.
J Allergy Clin Immunol. 1998 Nov;102(5):876-7. doi: 10.1016/s0091-6749(98)70032-6.
8
The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis.
Am J Respir Crit Care Med. 1995 Jun;151(6):1734-9. doi: 10.1164/ajrccm.151.6.7767514.
Zotero 插件